Fredun Pharmaceuticals Limited
₹1,392.80-₹57.80 (-3.98%)
Fredun Pharmaceuticals Limited’s quoted price sits in the upper half of its reported 52-week range, 16.42% below the high.
BSE · HSIL.BO · INR
Stock price
Quote as of Oct 30, 2026, 04:54 AM UTC. Cached market data; not a live quote.
One-year closing-price history · INR. Historical prices are not a forecast.
Hemant Surgical Industries Ltd.’s quoted price sits in the upper half of its reported 52-week range, 15.39% below the high.
52-week range
Go beyond this overview with deeper company research in PortfolioX. Explore more in the app
THE COMPANY BEHIND THE TICKER
Hemant Surgical Industries Ltd. functions as a pharmaceutical enterprise, focusing on the import, production, and distribution of both surgical equipment and pharmaceutical items. Hanskumar Shamji Shah established the firm in 1985, and its primary operations are based in Mumbai, India.
Latest available per-share figures in INR. The payout ratio compares dividends with earnings.
About this data · PortfolioX market data, also available in the mobile app. Prices are displayed in the listing currency; dividend amounts use the currency shown in that section. Data availability and update times vary.
Page generated Oct 30, 2026, 05:25 AM UTC. Quotes retain their own timestamp above. Missing values appear as a dash. This page is for information only, not personalized investment advice.
HOW THE BUSINESS IS PERFORMING
Statement amounts use the company’s reporting currency and are not converted to the stock’s listing currency. K = thousand, M = million, B = billion, T = trillion. Cash-flow figures are matched by fiscal year; missing figures appear as a dash.
PUT THE NUMBERS IN CONTEXT
Current metrics alongside available historical medians. A lower multiple or higher margin alone does not establish whether a stock is a good investment.
KEEP COMPARING
₹1,392.80-₹57.80 (-3.98%)
Fredun Pharmaceuticals Limited’s quoted price sits in the upper half of its reported 52-week range, 16.42% below the high.
₹98.80+₹1.28 (+1.31%)
Themis Medicare Limited’s quoted price sits in the lower half of its reported 52-week range, 29.73% below the high.
₹422.60-₹8.05 (-1.87%)
Trident Lifeline Limited’s quoted price sits in the upper half of its reported 52-week range, 3.49% below the high.
₹38.06+₹0.11 (+0.29%)
Zenotech Laboratories Limited’s quoted price sits in the lower half of its reported 52-week range, 29.7% below the high.
₹400.00-₹0.30 (-0.07%)
BDH Industries Limited’s quoted price sits in the lower half of its reported 52-week range, 34.43% below the high.
₹171.70+₹3.30 (+1.96%)
Sanjivani Paranteral Limited.’s quoted price sits in the lower half of its reported 52-week range, 29.63% below the high.
₹102.50₹0.00 (0.0%)
Raaj Medisafe India Limited’s quoted price sits in the upper half of its reported 52-week range, 7.57% below the high.
₹190.05₹0.00 (0.0%)
Makers Laboratories Limited’s quoted price sits in the upper half of its reported 52-week range, 20.48% below the high.